All bills
S. 5502·119th Congress·Senate Bill

Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (24 Sep 2026): Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

What this bill does

S. 5502, the Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act, would amend the Homeland Security Act of 2002. Specifically, it aims to include biotechnology and biomanufacturing infrastructure within the scope of protections provided by the Cybersecurity and Infrastructure Security Agency (CISA) of the Department of Homeland Security. This would involve CISA developing plans and taking actions to protect these types of infrastructure, especially in cases where a specific government agency has not been designated to oversee them. The bill also requires CISA to coordinate with industry groups and specific organizations like BIO-ISAC and H-ISAC.

The bill would affect owners and operators of biotechnology and biomanufacturing infrastructure. It mandates that CISA create a work plan within 45 days of enactment, identifying stakeholders and outlining outreach and engagement strategies. CISA would also be required to submit an implementation report one year after the work plan is submitted, and another report addressing unprotected critical biotechnology areas within two years.

This bill was introduced in the Senate on September 24, 2026, by Senator Maggie Hassan and is cosponsored by Senator Young. It has been referred to the Committee on Homeland Security and Governmental Affairs. The next step in the legislative process would be for this committee to consider the bill.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 24 Sep 2026

    Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Common questions

What does S. 5502 do?
S. 5502, the Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act, would amend the Homeland Security Act of 2002. Specifically, it aims to include biotechnology and biomanufacturing infrastructure within the scope of protections provided by the Cybersecurity and Infrastructure Security Agency (CISA) of the Department of Homeland Security. This would involve CISA developing plans and taking actions to protect these types of infrastructure, especially in cases where a specific government agency has not been designated to oversee them. The bill also requires CISA to coordinate with industry groups and specific organizations like BIO-ISAC and H-ISAC. The bill would affect owners and operators of biotechnology and biomanufacturing infrastructure. It mandates that CISA create a work plan within 45 days of enactment, identifying stakeholders and outlining outreach and engagement strategies. CISA would also be required to submit an implementation report one year after the work plan is submitted, and another report addressing unprotected critical biotechnology areas within two years. This bill was introduced in the Senate on September 24, 2026, by Senator Maggie Hassan and is cosponsored by Senator Young. It has been referred to the Committee on Homeland Security and Governmental Affairs. The next step in the legislative process would be for this committee to consider the bill.
Has S. 5502 become law?
The source does not supply a confirmed lifecycle stage for S. 5502. Check the latest action and official source below.
Who sponsored S. 5502?
S. 5502 was sponsored by Sen. Hassan, Margaret Wood [D-NH] (D-NH), with 1 cosponsor.
What's the latest action on S. 5502?
Read twice and referred to the Committee on Homeland Security and Governmental Affairs. (24 Sep 2026).

Related bills in Science, Technology, Communications

More bills from Sen. Hassan, Margaret Wood [D-NH]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.